
Aker BioMarine AS
- Jurisdiction
Norway - LEI
549300V34T6VWDSYWE64 - ISIN
NO0010886625 (AKBM.OL )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
7
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
3
/ 7
Profile
Aker BioMarine AS develops, produces, and sells krill-derived ingredients for nutraceutical, dietary supplement, and animal feed applications in Norway, the Americas, the Asia Pacific, Europe, the Middle East, and Africa. Read full profile
Stock price
Fundamentals
- Net revenue
€177.95M - Gross margin
39.7% - EBIT
€1.72M - EBIT margin
1.0% - Net income
€149.21M - Net margin
83.8%
Statement period: - (published )
Dividends
- Last dividend amount
-
NOK 45.00 - Ex date
-
- Payment date
-
- Dividend payout ratio
-
214.6%